Suchergebnis | Hamburg Open Science

Facetten

21 Einträge gefunden

Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer.
2010 - Forschungsinformationssystem des UKE
Unilateral prostate cancer cannot be accurately predicted in low-risk patients.
2009 - Forschungsinformationssystem des UKE
Prediction of sexual function after radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
2009 - Forschungsinformationssystem des UKE
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.
2008 - Forschungsinformationssystem des UKE
Is node-positive prostate cancer always a systemic disease?
2008 - Forschungsinformationssystem des UKE
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
2008 - Forschungsinformationssystem des UKE
Prostate cancer diagnosis: importance of individualized risk stratification models over PSA alone.
2008 - Forschungsinformationssystem des UKE
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level
2008 - Forschungsinformationssystem des UKE
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.
2007 - Forschungsinformationssystem des UKE
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
2007 - Forschungsinformationssystem des UKE
Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.
2007 - Forschungsinformationssystem des UKE
Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin.
2007 - Forschungsinformationssystem des UKE
Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
2007 - Forschungsinformationssystem des UKE
Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.
2007 - Forschungsinformationssystem des UKE
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
2007 - Forschungsinformationssystem des UKE
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
2007 - Forschungsinformationssystem des UKE
Management of erectile dysfunction after radical prostatectomy in 2007.
2007 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer.

Unilateral prostate cancer cannot be accurately predicted in low-risk patients.

Prediction of sexual function after radical prostatectomy.

Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.

Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.

Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.

Is node-positive prostate cancer always a systemic disease?

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

Prostate cancer diagnosis: importance of individualized risk stratification models over PSA alone.

Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.

Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.

A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.

Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.

Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin.

Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.

Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy.

Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.

Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.

Management of erectile dysfunction after radical prostatectomy in 2007.